Alladapt Immunotherapeutics

Acquisition, funding and merger involving Alladapt Immunotherapeutics.

• Alladapt Immunotherapeutics has just announced a $119 Million fundraising (posted on June 23 2022).

View the org chart displaying its 16 main executives

Most searched biographies at Alladapt Immunotherapeutics

• Ashley Dombkowski, Chief Executive Officer
• Stacey Seltzer, Director
• Travis Wilson, Director

Create your alert
to follow the executive moves at Alladapt Immunotherapeutics.

Alladapt Immunotherapeutics has 2,282 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Endeavor BioMedicines has just announced a $132 Million fundraising (posted on April 25 2024).
• Metsera has just announced a $290 Million fundraising (posted on April 23 2024).
• Histogen has filed for bankruptcy protection  (posted on April 19 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion
• Vik Bajaj - Director at Interline Therapeutics

Learn more about the Biotechnology industry >

Press releases by Alladapt Immunotherapeutics

• Alladapt Immunotherapeutics

Social media about Alladapt Immunotherapeutics

• Alladapt Immunotherapeutics on Wikipedia, Google News & Yahoo Finance
• Alladapt Immunotherapeutics on LinkedIn, Twitter & YouTube

Contact by email its executives including Ashley Dombkowski

Call Alladapt Immunotherapeutics at +1 650...

View the org chart

Register to receive your alert

Report an error